Latest Blog Posts Tagged "National Institute of Neurological Disorders and Stroke (NINDS)"
November 20, 2015
More than 100 U.S. Representatives ask the House and Senate to work together to increase NIH funding.
October 20, 2014
A clinical trial of a compound with potential to slow disease progression is recruiting newly diagnosed PD patients not yet in need of symptomatic therapy to test the drug's efficacy.
July 30, 2014
Scientists have found six new gene variants associated with Parkinson's, which could point to new treatment paths.
April 04, 2014
WHAM in Rochester, New York ran a piece on the Phase III study of isradipine happening at the University of Rochester. MJFF funded Phase II.
Podcast: Drug That May Slow Parkinson's Progression Granted $23 Million from NIH for Phase III Testing
March 31, 2014
Tanya Simuni, MD, principal investigator of the STEADY-PD, and MJFF CEO Todd Sherer talk about the study of isradipine, recently granted $23 million from the NIH for Phase III testing.
February 21, 2014
Today, there is a specific opportunity for people who do not have Parkinson's disease (PD) to contribute to research by serving as control volunteers.
November 25, 2013
The new findings were published online in the journal Nature.
January 17, 2013
This week, the National Institute of Neurological Disorders and Stroke (NINDS) announced a critical new initiative to find Parkinson's biomarkers.